STOCK PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic drop today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that